Alignment Healthcare, Inc.
ALHC Healthcare Healthcare Plans
Alignment Healthcare, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.9 billion, up 46.1% from fiscal 2024. In the quarter to June 2026, revenue grew 31.6%, EPS grew 125.0%, free cash flow fell 229.5% and total debt was flat, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
Follow ALHC
Alignment Healthcare, Inc. (ALHC) EV/Sales
As of 13 October 2026, Alignment Healthcare, Inc. (ALHC) trades at a EV/Sales of 0.3×. Over the past ten years it has ranged from 0.3× (October 2026) to 3.8× (June 2021); the current reading is higher than 1% of that period. That is below the Healthcare Plans industry median of 0.4× and below the Healthcare sector median of 3.5×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 0.9× | 24.39% |
| FY2024 | 0.7× | (5.32%) |
| FY2023 | 0.8× | (39.64%) |
| FY2022 | 1.3× | (28.13%) |
| FY2021 | 1.8× | (32.83%) |
| FY2020 | 2.7× | 0.00% |
| FY2019 | 2.7× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 1.0× | 31.90% |
| Mar 2026 | 0.8× | (17.81%) |
| Dec 2025 | 0.9× | 6.07% |
| Sep 2025 | 0.9× | 11.38% |
| 23 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| CNC Centene Corporation compare | 0.1× |
| MOH Molina Healthcare, Inc compare | 0.1× |
| HUM Humana Inc. compare | 0.3× |
| ALHC Alignment Healthcare, Inc. | 0.3× |
| CI Cigna Group compare | 0.4× |
| ELV Elevance Health, Inc. compare | 0.4× |
| OSCR Oscar Health, Inc. compare | 0.4× |
| CLOV Clover Health Investments, Corp. compare | 0.9× |
| PGNY Progyny, Inc. compare | 1.5× |
| Healthcare Plans industry median | 0.4× |
| Healthcare sector median | 3.5× |
| Market median | 2.2× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)